Application of the Radical Cascade of Acyclic Peptide-Based Precursors into Analogues of Type I β-Turn

Abstract

Radical cyclizations of di-, tri- and tetrapeptides containing N-2-bromobenzyl,N-methyl-substituted alanine or aspartic acid lead in good yields to α,β-unsaturated γ-lactams. The overall cascade, relying on a hydrogen atom transfer-elimination strategy could serve as a way to incorporate a flat and rigid five-membered ring into the peptide framework.

domino reactions - peptides - protecting groups - radicals - ring constructions

References

1a Creighton CJ. Zapf CW. Bu JH. Goodman M. Org. Lett.  1999,  1:  1407 

1b Euguchi M. Lee MS. Nakanishi H. Stasiak M. Lovell S. Kahn M. J. Am. Chem. Soc.  1999,  121:  12204 

1c Spaller MR. Burger MT. Fardis M. Bartlett PA. Curr. Opin. Chem. Biol.  1997,  1:  47 

2a Smith LR. Bartlett PA. Molecules Online  1998,  2:  58 

2b Rose GD. Gierasch LM. Smith JA. Adv. Protein Chem.  1985,  37:  1 

3 Kahn M. Synlett  1993,  821 

4a Khalil EM. Ojala WH. Pradhan A. Nair VD. Gleason WB. Mishra RK. Johnson RL. J. Med. Chem.  1999,  42:  628 

4b Johannesson P. Lindeberg G. Tong W. Gogoll A. Karlén A. Hallberg A. J. Med. Chem.  1999,  42:  601 

4c Hirschmann R. Hynes J. Cichy-Knight MA. van Rijn RD. Sprengeler PA. Spoors PG. Shakespeare WC. Pietranico-Cole S. Barbosa J. Liu J. Yao W. Rohrer S. Smith AB. J. Mol. Chem.  1998,  41:  1382 

4d Fink BE. Kym PR. Katzenellenbogen JA. J. Am. Chem. Soc.  1998,  120:  4334 

4e Hanessian S. Huynh HK. Reddy GV. McNaughton-Smith G. Ernst B. Kolb HC. Magnani J. Sweeley C. Bioorg. Med. Chem. Lett.  1998,  8:  2803 

4f Hanessian S. McNaughton-Smith G. Lombart HG. Lubell WD. Tetrahedron  1997,  53:  12789 

5a Freidinger RM. Perlow DS. Veber DF. J. Org. Chem.  1982,  47:  104 

5b Freidinger RM. Perlow DS. Veber DF. Brooks JR. Saperstein R. Science  1980,  210:  656 

6a Genin MJ. Johnson RL. J. Am. Chem. Soc.  1992,  114:  8778 

6b Genin MJ. Ojala WH. Gleason WB. Johnson RL. J. Org. Chem.  1993,  58:  2334 

6c Hinds MG. Richards NGJ. J. Chem. Soc., Chem. Commun.  1988,  1447 

6d Hinds MG. Welsh JH. Brennand DM. Fisher J. Glennie MJ. Richards NGJ. Turner DL. Robinson JA. J. Med. Chem.  1991,  34:  1777 

7a Nagai U. Sato K. Nakamura R. Kato R. Tetrahedron  1993,  49:  3577 

7b Nagai U. Sato K. Tetrahedron Lett.  1985,  26:  647 

8a Kahn M. Wilke S. Chen B. Fujika K. J. Am. Chem. Soc.  1988,  110:  1638 

8b Kahn M. Wilke S. Chen B. Fujika K. Lee Y.-H. Johnson ME. J. Mol. Recognit.  1988,  1:  75 

8c Kahn M. Nakanishi H. Chrusciel RA. Fitzpatrick D. Johnson ME. J. Med. Chem.  1991,  34:  3395 

8d Olson GL. Voss ME. Hill DE. Kahn M. Madison VS. Cook CM. J. Am. Chem. Soc.  1990,  112:  323 

8e Kemp DS. McNamara P. Tetrahedron Lett.  1982,  23:  3761 

8f Kemp DS. Stites WE. Tetrahedron Lett.  1988,  29:  5057 

9 Easton CJ. Chem. Rev.  1997,  97:  53 

10a Blakskjaer P. Pedersen L. Skrydstrup T. J. Chem. Soc., Perkin Trans. 1  2001,  910 

10b Renaud P. Giraud L. Synthesis  1996,  913 

11a Wyss C. Batra R. Lehmann C. Sauer S. Giese B. Angew. Chem., Int. Ed. Engl.  1996,  35:  2529 

11b Sauer S. Staehelin C. Wyss C. Giese B. Chimia  1997,  51:  23 

11c Sauer S. Schumacher A. Barbosa F. Giese B. Tetrahedron Lett.  1998,  39:  3685 

11d Rancourt J. Gorys V. Jolicoeur E. Tetrahedron Lett.  1998,  39:  5339 

11e Giese B. Wettstein P. Stahelin C. Barbosa F. Neuburger M. Zehnder M. Wessig P. Angew. Chem. Int. Ed.  1999,  38:  2586 

11f Giese B. Barbosa F. Stahelin C. Sauer S. Wettstein P. Wyss C. Pure Appl. Chem.  2000,  72:  1623 

12 Andrukiewicz R. Loska R. Prisyahnyuk V. Staliñski K. J. Org. Chem.  2003,  68:  1552 

13a Curran DP. Xu J. J. Am. Chem. Soc.  1988,  110:  5900 

13b Curran DP. Yu H. Synthesis  1992,  123 

13c Curran DP. Xu J. J. Am. Chem. Soc.  1988,  118:  3142 

14 Stork G. Sher PM. J. Am. Chem. Soc.  1986,  108:  303 

15a Goodall K. Parsons AF. Tetrahedron  1996,  52:  6739 

15b Ishibashi H. Matsukida H. Toyao A. Tamura O. Takeda Y. Synlett  2000,  1497 

16

Spectroscopic data of compounds 8-12:
2-[2-(3,4-Dimethyl-2-oxo-2,5-dihydro-pyrrol-1-yl)acetylamino]propionic Acid tert -Butyl Ester (8): IR (film): 3297, 3065, 2979, 2923, 1738, 1667, 1544, 1457, 1226, 1152 cm^-1. ¹H NMR: δ = 6.55 (1 H, br d, J = 6.7 Hz), 4.46-4.39 (1 H, quintet, J = 7.2 Hz), 4.21-3.96 (2 H, AB system, J = 16.3 Hz), 3.94-3.81 (2 H, AB system, J = 18.2 Hz), 1.98 (3 H, s), 1.82 (3 H, d, J = 0.9 Hz), 1.45 (9 H, s), 1.36 (3 H, d, J = 7.2 Hz) ppm. ¹³C NMR: δ = 173.4, 171.8, 168.2, 147.4, 128.3, 82.0, 55.3, 48.7, 46.5, 27.9, 18.4, 13.1, 8.6 ppm. MS (ESI): m/z = 319 [M⁺ + Na]. HRMS (ESI): m/z calcd for C₁₅H₂₄O₄N₂Na: 319.1628; found: 319.1644.
(3- tert -Butoxycarbonylmethyl-2-oxo-4-trimethylsilanyl-methyl-2,5-dihydropyrrol-1-yl)acetic Acid Methyl Ester (9): IR (film): 1736, 1687, 1456, 1368, 1327, 1251, 1214, 1148, 849 cm^-1. ¹H NMR: δ = 4.22 (2 H, s), 3.91 (2 H, s), 3.72 (3 H, s), 3.18 (2 H, s), 1.91 (2 H, s), 1.44 (9 H, s), 0.09 (9 H, s) ppm. ¹³C NMR: δ = 172.0, 170.0, 169.5, 153.5, 123.1, 80.9, 54.9, 52.1, 43.3, 30.7, 28.0, 20.1, -1.0 ppm. MS [LSIMS(+)]: m/z = 356 [M⁺ + H], 378 [M⁺ + Na]. HRMS [LSIMS(+)]: m/z calcd for C₁₇H₃₀O₅NSi: 356.1893; found: 356.1905.
2-[2-(1-Methoxycarbonylmethyl-2-oxo-4-trimethyl-silanylmethyl-2,5-dihydro-1 H -pyrrol-3-ylacetyl-amino]propionic Acid tert -Butyl Ester (10): IR (film): 3299, 3064, 1741, 1667, 1537, 1457, 1369, 1220, 1152 cm^-1. ¹H NMR: δ = 7.30 (1 H, m), 4.38-4.31 (1 H, quintet, J = 7.2 Hz), 4.29-4.19 (2 H, AB system, J = 17.8 Hz), 3.98 (2 H, s), 3.73 (3 H, s), 3.27 (2 H, s), 2.09 (3 H, s), 1.43 (9 H, s), 1.35-1.33 (3 H, d, J = 7.1 Hz) ppm. ¹³C NMR: δ = 172.6, 171.8, 169.5, 168.8, 128.8, 126.3, 81.6, 55.3, 52.2, 49.0, 43.5, 34.5, 27.9, 18.1, 13.3 ppm. MS (ESI): m/z = 377 [M⁺ + Na]. HRMS (ESI): m/z calcd for C₁₇H₂₆O₆N₂Na: 377.1683; found: 377.1697.
2-[2-(3- tert -Butoxycarbonylmethyl-4-methyl-2-oxo-2,5-dihydropyrrol-1-yl)acetylamino]propionic Acid Benzyl Ester (11): IR (film): 3297, 3066, 1734, 1670, 1541, 1457, 1326, 1151, 747 cm^-1. ¹H NMR: δ = 7.38-7.31 (5 H, m), 6.62-6.57 (1 H, br d, J = 7.5 Hz), 5.19-5.10 (2 H, AB system, J = 12.3 Hz), 4.63-4.57 (1 H, quintet, J = 7.3 Hz), 4.24-3.95 (2 H, AB system, J = 16.2 Hz), 3.97-3.85 (2 H, AB system, J = 18.7 Hz), 3.24 (2 H, s), 2.00 (3 H, s), 1.45 (9 H, s), 1.42-1.40 (3 H, d, J = 7.2 Hz) ppm. ¹³C NMR: δ = 172.4, 172.2, 169.3, 168.4, 151.2, 135.4, 128.6, 128.4, 128.1, 126.3, 81.2, 67.1, 55.5, 48.1, 46.6, 30.3, 28.0, 18.0, 13.5 ppm. MS [LSIMS(+)]: m/z = 431 [M⁺ + H], 453 [M⁺ + Na]. HRMS [LSIMS(+)]: m/z calcd for C₂₃H₃₁O₆N₂: 431.2182; found: 431.2189.
2-(2-{1-[(1- tert -Butoxycarbonylethylcarbamoyl)methyl]-4-methyl-2-oxo-2,5-dihydro-1 H -pyrrol-3-yl}acetyl-amino)propionic Acid tert -Butyl Ester (12): IR (film): 3299, 3065, 1736, 1659, 1543, 1455, 1368, 1226, 1152 cm^-1. ¹H NMR: δ = 7.30 (1 H, br s), 6.59 (1 H, br s), 4.60-3.90 (6 H, m), 3.26 (2 H, s), 2.09 (3 H, s), 1.45 (9 H, s), 1.44 (9 H, s), 1.37 (3 H, d, J = 7.2 Hz), 1.34 (3 H, d, J = 7.3 Hz) ppm. ¹³C NMR: δ = 172.8, 171.9, 171.8, 168.6, 167.7, 152.0, 128.7, 81.5 (2×), 55.8, 48.9, 48.8, 46.4, 32.5, 27.9 (2×), 18.3, 18.4, 13.4 ppm. MS (ESI): m/z = 468 [M⁺ + H], 490 [M⁺ + Na]. HRMS (ESI): m/z calcd for C₂₃H₃₇O₇N₃Na: 490.2524; found: 490.2542.

17a Stork G. Mah R. Heterocycles  1989,  28:  723 

17b Curran DP. Tamine J. J. Org. Chem.  1991,  56:  2746 

17c Curran DP. Liu W. Chen CH.-T. J. Am. Chem. Soc.  1999,  121:  11012 

18 Strub W. Roduner E. Fisher H. J. Phys. Chem.  1987,  91:  4379 

19 Musa OM. Horner JH. Newcomb M. J. Org. Chem.  1999,  64:  1022